Literature DB >> 29630898

Gut Microbiota Promotes Tumor Growth in Mice by Modulating Immune Response.

Vrishketan Sethi1, Saba Kurtom1, Mohammad Tarique1, Shweta Lavania1, Zoe Malchiodi1, Leonor Hellmund1, Li Zhang1, Umakant Sharma1, Bhuwan Giri1, Bharti Garg1, Anthony Ferrantella1, Selwyn M Vickers2, Sulagna Banerjee1, Rajinder Dawra1, Sabita Roy1, Sundaram Ramakrishnan1, Ashok Saluja1, Vikas Dudeja3.   

Abstract

We studied the effects of gut microbiome depletion by oral antibiotics on tumor growth in subcutaneous and liver metastases models of pancreatic cancer, colon cancer, and melanoma. Gut microbiome depletion significantly reduced tumor burden in all the models tested. However, depletion of gut microbiome did not reduce tumor growth in Rag1-knockout mice, which lack mature T and B cells. Flow cytometry analyses demonstrated that gut microbiome depletion led to significant increase in interferon gamma-producing T cells with corresponding decrease in interleukin 17A and interleukin 10-producing T cells. Our results suggest that gut microbiome modulation could emerge as a novel immunotherapeutic strategy.
Copyright © 2018 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Gut Bacteria; Immune Regulation; Metastases; Tumor Promotion

Mesh:

Substances:

Year:  2018        PMID: 29630898      PMCID: PMC6035070          DOI: 10.1053/j.gastro.2018.04.001

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  11 in total

1.  Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice.

Authors:  Sunil R Hingorani; Lifu Wang; Asha S Multani; Chelsea Combs; Therese B Deramaudt; Ralph H Hruban; Anil K Rustgi; Sandy Chang; David A Tuveson
Journal:  Cancer Cell       Date:  2005-05       Impact factor: 31.743

2.  Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma.

Authors:  Rafael Winograd; Katelyn T Byrne; Rebecca A Evans; Pamela M Odorizzi; Anders R L Meyer; David L Bajor; Cynthia Clendenin; Ben Z Stanger; Emma E Furth; E John Wherry; Robert H Vonderheide
Journal:  Cancer Immunol Res       Date:  2015-02-12       Impact factor: 11.151

3.  Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth.

Authors:  Sergei I Grivennikov; Kepeng Wang; Daniel Mucida; C Andrew Stewart; Bernd Schnabl; Dominik Jauch; Koji Taniguchi; Guann-Yi Yu; Christoph H Osterreicher; Kenneth E Hung; Christian Datz; Ying Feng; Eric R Fearon; Mohamed Oukka; Lino Tessarollo; Vincenzo Coppola; Felix Yarovinsky; Hilde Cheroutre; Lars Eckmann; Giorgio Trinchieri; Michael Karin
Journal:  Nature       Date:  2012-11-08       Impact factor: 49.962

4.  IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway.

Authors:  Lin Wang; Tangsheng Yi; Marcin Kortylewski; Drew M Pardoll; Defu Zeng; Hua Yu
Journal:  J Exp Med       Date:  2009-06-29       Impact factor: 14.307

5.  Oncogenic Kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasia.

Authors:  Florencia McAllister; Jennifer M Bailey; Janivette Alsina; Christopher J Nirschl; Rajni Sharma; Hongni Fan; Yanique Rattigan; Jeffrey C Roeser; Rachana H Lankapalli; Hao Zhang; Elizabeth M Jaffee; Charles G Drake; Franck Housseau; Anirban Maitra; Jay K Kolls; Cynthia L Sears; Drew M Pardoll; Steven D Leach
Journal:  Cancer Cell       Date:  2014-05-12       Impact factor: 31.743

Review 6.  Interactions between the microbiota and the immune system.

Authors:  Lora V Hooper; Dan R Littman; Andrew J Macpherson
Journal:  Science       Date:  2012-06-06       Impact factor: 47.728

7.  Depletion of murine intestinal microbiota: effects on gut mucosa and epithelial gene expression.

Authors:  Dag Henrik Reikvam; Alexander Erofeev; Anders Sandvik; Vedrana Grcic; Frode Lars Jahnsen; Peter Gaustad; Kathy D McCoy; Andrew J Macpherson; Leonardo A Meza-Zepeda; Finn-Eirik Johansen
Journal:  PLoS One       Date:  2011-03-21       Impact factor: 3.240

8.  Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer.

Authors:  Lucia De Monte; Michele Reni; Elena Tassi; Daniela Clavenna; Ilenia Papa; Helios Recalde; Marco Braga; Valerio Di Carlo; Claudio Doglioni; Maria Pia Protti
Journal:  J Exp Med       Date:  2011-02-21       Impact factor: 14.307

9.  Braf(V600E) cooperates with Pten loss to induce metastatic melanoma.

Authors:  David Dankort; David P Curley; Robert A Cartlidge; Betsy Nelson; Anthony N Karnezis; William E Damsky; Mingjian J You; Ronald A DePinho; Martin McMahon; Marcus Bosenberg
Journal:  Nat Genet       Date:  2009-03-12       Impact factor: 38.330

10.  Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine.

Authors:  Ivaylo I Ivanov; Rosa de Llanos Frutos; Nicolas Manel; Keiji Yoshinaga; Daniel B Rifkin; R Balfour Sartor; B Brett Finlay; Dan R Littman
Journal:  Cell Host Microbe       Date:  2008-10-16       Impact factor: 21.023

View more
  92 in total

1.  Microbial dysbiosis and polyamine metabolism as predictive markers for early detection of pancreatic cancer.

Authors:  Roberto Mendez; Kousik Kesh; Nivedita Arora; Leá Di Martino; Florencia McAllister; Nipun Merchant; Sulagna Banerjee; Santanu Banerjee
Journal:  Carcinogenesis       Date:  2020-07-10       Impact factor: 4.944

Review 2.  Cellular determinants and therapeutic implications of inflammation in pancreatic cancer.

Authors:  Meredith L Stone; Gregory L Beatty
Journal:  Pharmacol Ther       Date:  2019-05-31       Impact factor: 12.310

Review 3.  Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome-driven neoplasms.

Authors:  Tsuyoshi Hamada; Jonathan A Nowak; Danny A Milner; Mingyang Song; Shuji Ogino
Journal:  J Pathol       Date:  2019-02-20       Impact factor: 7.996

4.  Gut microbiome-immune crosstalk affects progression of cancer.

Authors:  Herbert Tilg; Andreas Schmiderer; Angela Djanani
Journal:  Transl Gastroenterol Hepatol       Date:  2018-06-19

5.  AI finds microbial signatures in tumours and blood across cancer types.

Authors:  Nadim J Ajami; Jennifer A Wargo
Journal:  Nature       Date:  2020-03       Impact factor: 49.962

6.  Rethinking research into metastasis.

Authors:  Peter Friedl
Journal:  Elife       Date:  2019-12-17       Impact factor: 8.140

Review 7.  Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders.

Authors:  Daniel M Chopyk; Arash Grakoui
Journal:  Gastroenterology       Date:  2020-06-20       Impact factor: 22.682

Review 8.  Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome.

Authors:  Ziying Zhang; Haosheng Tang; Peng Chen; Hui Xie; Yongguang Tao
Journal:  Signal Transduct Target Ther       Date:  2019-10-12

Review 9.  The Gut Microbiome in Pancreatic Disease.

Authors:  Venkata S Akshintala; Rupjyoti Talukdar; Vikesh K Singh; Michael Goggins
Journal:  Clin Gastroenterol Hepatol       Date:  2018-08-23       Impact factor: 11.382

10.  Metformin alters the duodenal microbiome and decreases the incidence of pancreatic ductal adenocarcinoma promoted by diet-induced obesity.

Authors:  Tien S Dong; Hui-Hua Chang; Meg Hauer; Venu Lagishetty; William Katzka; Enrique Rozengurt; Jonathan P Jacobs; Guido Eibl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-09-23       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.